Piper Sandler upgraded shares of IO Biotech (NASDAQ:IOBT – Free Report) to a strong-buy rating in a report published on Wednesday morning,Zacks.com reports.
Separately, HC Wainwright reissued a “buy” rating and set a $12.00 price target on shares of IO Biotech in a research report on Wednesday, March 5th.
View Our Latest Stock Analysis on IO Biotech
IO Biotech Stock Down 1.3 %
Institutional Investors Weigh In On IO Biotech
Several hedge funds and other institutional investors have recently added to or reduced their stakes in IOBT. Vontobel Holding Ltd. purchased a new stake in shares of IO Biotech in the fourth quarter worth about $30,000. Citadel Advisors LLC purchased a new position in IO Biotech during the fourth quarter valued at approximately $249,000. Renaissance Technologies LLC lifted its holdings in IO Biotech by 22.5% in the fourth quarter. Renaissance Technologies LLC now owns 118,800 shares of the company’s stock valued at $109,000 after acquiring an additional 21,800 shares during the period. XTX Topco Ltd purchased a new stake in IO Biotech in the 4th quarter worth approximately $26,000. Finally, Dauntless Investment Group LLC purchased a new stake in IO Biotech in the 4th quarter worth approximately $688,000. 54.76% of the stock is owned by institutional investors and hedge funds.
IO Biotech Company Profile
IO Biotech, Inc, a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer.
See Also
- Five stocks we like better than IO Biotech
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- What is the MACD Indicator and How to Use it in Your Trading
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for IO Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IO Biotech and related companies with MarketBeat.com's FREE daily email newsletter.